BACKGROUND: Trigger tools are an important development in the identification and reduction of adverse drug events (ADEs). Most previously published triggers are simple, consisting of one or two conditions. Simple logic may lead to alerts for conditions not caused by a drug or already treated by the provider. METHODS: We created a knowledge-encoding tool to develop outpatient ADE triggers to more specifically identify harm caused by a drug and which require further clinical intervention. The tool presented the user with data on similar triggers from the literature and a series of fields to facilitate the creation of algorithms based on epidemiological principles. RESULTS: Using this tool, we created 23 triggers that addressed 55 high-harm outpatient drugs and ADEs. CONCLUSION: Informatics tools can facilitate the design of clinically rich triggers. More investigation is needed to determine whether the performance characteristics of clinically rich triggers are better than those of simple triggers.
BACKGROUND: Trigger tools are an important development in the identification and reduction of adverse drug events (ADEs). Most previously published triggers are simple, consisting of one or two conditions. Simple logic may lead to alerts for conditions not caused by a drug or already treated by the provider. METHODS: We created a knowledge-encoding tool to develop outpatient ADE triggers to more specifically identify harm caused by a drug and which require further clinical intervention. The tool presented the user with data on similar triggers from the literature and a series of fields to facilitate the creation of algorithms based on epidemiological principles. RESULTS: Using this tool, we created 23 triggers that addressed 55 high-harm outpatient drugs and ADEs. CONCLUSION: Informatics tools can facilitate the design of clinically rich triggers. More investigation is needed to determine whether the performance characteristics of clinically rich triggers are better than those of simple triggers.
Authors: David W Bates; R Scott Evans; Harvey Murff; Peter D Stetson; Lisa Pizziferri; George Hripcsak Journal: J Am Med Inform Assoc Date: 2003 Mar-Apr Impact factor: 4.497
Authors: Shobha Phansalkar; Jennifer M Hoffman; Jonathan R Nebeker; John F Hurdle Journal: Am J Health Syst Pharm Date: 2007-04-15 Impact factor: 2.637
Authors: Paul J Sharek; Jeffrey D Horbar; Wilbert Mason; Hema Bisarya; Cary W Thurm; Gautham Suresh; James E Gray; William H Edwards; Donald Goldmann; David Classen Journal: Pediatrics Date: 2006-10 Impact factor: 7.124
Authors: Daniel S Budnitz; Daniel A Pollock; Kelly N Weidenbach; Aaron B Mendelsohn; Thomas J Schroeder; Joseph L Annest Journal: JAMA Date: 2006-10-18 Impact factor: 56.272
Authors: E S Kirkendall; W L Spires; T A Mottes; J K Schaffzin; C Barclay; S L Goldstein Journal: Appl Clin Inform Date: 2014-04-02 Impact factor: 2.342
Authors: Hillary J Mull; Jonathan R Nebeker; Stephanie L Shimada; Haytham M A Kaafarani; Peter E Rivard; Amy K Rosen Journal: J Patient Saf Date: 2011-06 Impact factor: 2.844
Authors: Hillary J Mull; Amy K Rosen; Stephanie L Shimada; Peter E Rivard; Brian Nordberg; Brenna Long; Jennifer M Hoffman; Molly Leecaster; Lucy A Savitz; Christopher W Shanahan; Amy Helwig; Jonathan R Nebeker Journal: EGEMS (Wash DC) Date: 2015-04-30